Workflow
企业易主
icon
Search documents
24.7%表决权到手 央企招商局集团入主人福医药只差“临门一脚”
Mei Ri Jing Ji Xin Wen· 2025-06-28 10:39
Core Viewpoint - The acquisition of Renfu Pharmaceutical by China Merchants Group has made significant progress, with the transfer of shares completed, leading to a control of 24.70% of voting rights by China Merchants Life Science [1][3][4] Group 1: Acquisition Details - On June 27, Renfu Pharmaceutical announced that its controlling shareholder, Contemporary Technology, has transferred 387 million shares through judicial means, completing the share registration process [1][3] - Following the transfer, China Merchants Life Science directly holds 97.93 million shares of Renfu Pharmaceutical, accounting for 6% of the total share capital [3] - China Merchants Life Science has also increased its stake by 1% from April 30 to June 11, 2025, leading to a total control of 24.70% of voting rights through direct and indirect holdings [3][4] Group 2: Financial Background - In 2024, Renfu Pharmaceutical achieved revenue of 25.435 billion yuan, a year-on-year increase of 3.71%, but its net profit attributable to shareholders decreased by 37.70% to 1.33 billion yuan [4] - China Merchants Group reported a total revenue of 916.7 billion yuan and a net profit of 187.2 billion yuan in 2024, showcasing its strong financial position [2] Group 3: Management Changes - Renfu Pharmaceutical has undergone significant management changes this year, including the resignation of its chairman and several board members, with new directors from China Merchants Group being appointed [4][5] - The new directors, while lacking direct experience in the anesthetics field, bring relevant experience from the health industry, indicating a strategic shift in management [5]
这家A股上市公司筹划易主,潮汕日化二代入局!股价连续6天涨停
Sou Hu Cai Jing· 2025-06-12 10:11
因为业绩惨淡"披星戴帽"的*ST赛隆(002898.SZ),近期的股价却异常疯狂。 自4月29日以来,*ST赛隆的股价如脱缰野马一路狂飙,从最低的5.77元,已涨至今日的10.71元,股价 大涨的背后,公司正在筹划易主。 赛隆药业筹划易主 公司股价连收6个涨停 5月20日,*ST赛隆公告显示,公司控股股东、实际控制人蔡南桂、唐霖与海南雅亿共赢科技合伙企业 (有限合伙)(以下简称"海南雅亿")签署了《关于赛隆药业集团股份有限公司之股份转让协议》。 蔡南桂、唐霖拟向海南雅亿转让其持有的公司14.16%股份。同时,蔡南桂、唐霖承诺自本次交易交割 日起至其不再持有公司股份之日止,无条件且不可撤销地承诺放弃行使其所持公司剩余股份所对应的除 收益权和股票处置权之外的全部股东权利。标的股份作价为8元/股,交易金额共计1.99亿元。 如此次交易顺利进行,海南雅亿将成为赛隆药业的控股股东。由于目前海南雅亿无实际控制人,故*ST 赛隆将变更为无实际控制人。 受这一消息影响,*ST赛隆股价持续大涨。东方财富显示,*ST赛隆已连续6个交易日涨停,截至今日收 盘,*ST赛隆报10.71元/股,总市值为18.85亿亿元。 接盘方实力不俗 ...